Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 36.74%
March 31, 2026 32.64%
December 31, 2025 30.93%
September 30, 2025 37.63%
June 30, 2025 37.96%
March 31, 2025 34.84%
December 31, 2024 35.74%
September 30, 2024 34.83%
June 30, 2024 34.53%
March 31, 2024 32.38%
December 31, 2023 26.84%
September 30, 2023 32.71%
June 30, 2023 33.54%
March 31, 2023 32.74%
December 31, 2022 28.41%
September 30, 2022 30.86%
June 30, 2022 28.36%
March 31, 2022 30.73%
December 31, 2021 36.51%
September 30, 2021 37.03%
June 30, 2021 37.37%
March 31, 2021 35.16%
December 31, 2020 36.52%
September 30, 2020 35.01%
June 30, 2020 34.34%
Date Value
March 31, 2020 36.74%
December 31, 2019 36.07%
September 30, 2019 38.48%
June 30, 2019 33.20%
March 31, 2019 40.84%
December 31, 2018 39.54%
September 30, 2018 41.08%
June 30, 2018 42.04%
March 31, 2018 39.99%
December 31, 2017 37.06%
September 30, 2017 32.36%
June 30, 2017 26.56%
March 31, 2017 35.90%
December 31, 2016 53.05%
September 30, 2016 52.80%
June 30, 2016 51.83%
March 31, 2016 54.79%
December 31, 2015 53.39%
September 30, 2015 53.79%
June 30, 2015 52.23%
March 31, 2015 52.17%
December 31, 2014 49.67%
September 30, 2014 49.25%
June 30, 2014 47.72%
March 31, 2014 49.20%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Baxter International, Inc. 33.55%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%